©The Author(s) 2022.
World J Gastroenterol. Nov 14, 2022; 28(42): 6056-6067
Published online Nov 14, 2022. doi: 10.3748/wjg.v28.i42.6056
Published online Nov 14, 2022. doi: 10.3748/wjg.v28.i42.6056
Table 1 Clinical characteristics of gastric cancer patients with postoperative chylous ascites
| Characteristics | Cases |
| Age, yr | 61.0 ± 11.3 |
| Gender, n (%) | |
| Male | 41 (77.4) |
| Female | 12 (22.6) |
| Tumor location, n (%) | |
| Upper | 18 (40.0) |
| Middle | 11 (20.6) |
| Bottom | 24 (45.3) |
| AJCC 8th stage, n (%) | |
| I | 21 (39.6) |
| II | 11 (20.8) |
| III | 18 (34.0) |
| IV | 3 (5.7) |
| Type of surgery, n (%) | |
| Radical | 51 (96.2) |
| Non-radical | 2 (3.8) |
| LN dissection, n (%) | |
| D1 | 8 (15.1) |
| D2 | 43 (81.1) |
| D3 | 2 (3.8) |
| Discharged without DT, n (%) | |
| Yes | 40 (75.5) |
| No | 13 (24.5) |
| Postoperative time of oral feeding (d) | 3.8 ± 1.0 |
| Postoperative time of CA appearance (d) | 7.5 ± 2.4 |
| DT removal duration (d) | 14.3 ± 12.6 |
| Postoperative hospitalization duration (d) | 21.9 ± 11.1 |
- Citation: Kong PF, Xu YH, Lai ZH, Ma MZ, Duan YT, Sun B, Xu DZ. Novel management indications for conservative treatment of chylous ascites after gastric cancer surgery. World J Gastroenterol 2022; 28(42): 6056-6067
- URL: https://www.wjgnet.com/1007-9327/full/v28/i42/6056.htm
- DOI: https://dx.doi.org/10.3748/wjg.v28.i42.6056